Project information
Central European Advanced Therapy and Immunotherapy Centre
(CREATIC)
- Project Identification
- 101059788
- Project Period
- 9/2023 - 8/2029
- Investor / Pogramme / Project type
-
European Union
- Horizon Europe
- Widening participation and strengthening the European Research Area
- MU Faculty or unit
-
Faculty of Medicine
- doc. MUDr. Regina Demlová, Ph.D.
- Ing. Ondřej Bar
- Mgr. Tomáš Bárta, Ph.D.
- PharmDr. Adéla Bártová
- Mgr. Petr Bureš
- PharmDr. Zora Čechová, Ph.D.
- Mgr. Barbora Čechovská
- Mgr. Kateřina Černá Pilátová, Ph.D.
- MUDr. Jiří Deml
- Ing. Lucie Flajšarová
- Mgr. Petr Fojtík, Ph.D.
- Mgr. Jakub Gregor, Ph.D.
- doc. MVDr. Aleš Hampl, CSc.
- Ing. Veronika Hlávková
- Mgr. et Mgr. Zuzana Hrabovská
- Mgr. Eva Hrubá, Ph.D.
- Mgr. Jakub Jamárik
- Mgr. Lucie Jurečková
- prof. MUDr. Tomáš Kašpárek, Ph.D.
- MUDr. Tomáš Kepák, Ph.D.
- RNDr. Martin Komenda, Ph.D., MBA
- Mgr. Tomáš Kopecký
- Mgr. Bc. Michal Koščík, Ph.D.
- Ing. Mgr. Alexandra Koutná
- Silvie Koutná
- Mgr. Jana Kubátová, Ph.D.
- MUDr. Michal Kýr, Ph.D.
- Ing. Sofiia Lymarenko
- MUDr. Tomáš Merta
- Mgr. Marie Mlnaříková
- MUDr. Peter Múdry, Ph.D.
- PharmDr. Adriána Papiež, Ph.D.
- Mgr. Vendula Pelková
- Mgr. Veronika Plachá
- prof. RNDr. Šárka Pospíšilová, Ph.D.
- MUDr. Ondřej Rohleder
- PharmDr. Jiří Samek
- Mgr. Jana Sedláková
- MUDr. Kateřina Slabá
- prof. RNDr. Ondřej Slabý, Ph.D.
- Mgr. Renata Slováčková
- Mgr. Tereza Souralová
- Mgr. Eva Šťastná
- prof. MUDr. Jaroslav Štěrba, Ph.D.
- MUDr. Martin Štěrba
- prof. MUDr. Petr Štourač, Ph.D., MBA, FESAIC
- Mgr. Gabriela Tomaštíková
- MUDr. Terézia Tureková
- prof. MUDr. Dalibor Valík, Ph.D., DABCC
- doc. RNDr. Petr Vaňhara, Ph.D.
- Ing. Eva Veselá
- Mgr. Eliška Vladíková
- Anastasiya Volakhava, M.Sc.
- prof. RNDr. Lenka Zdražilová Dubská, Ph.D.
- Cooperating Organization
-
University of Copenhagen
- Responsible person Jakob Wested
- Responsible person Maik Friedrich
- Responsible person Anna Duenkel
Progress in biomedical science enables us to use a whole new toolbox to treat significant groups of diseases, such as inherited rare diseases or diverse rare cancers. Advanced therapy medicinal products (ATMPs) apply recent advances in genomics, cell biology and/or gene editing to deliver truly personalized curative options. The project proposes to establish flagship ATMP-focused facility on the margin of academia and clinics: Central European Advanced Therapy and Immunotherapy Centre (CREATIC) at the Masaryk University (MUNI) in Brno, Czech Republic. MUNI will team up with the leading European research institutions: (1) Fraunhofer Institute for Cell Therapy and Immunology IZI, (2) Leipzig University, which together forms a significant cluster of research excellence in research, development and training in the fields of gene and cell therapies and (3) Copenhagen University with unique expertise in biomedical innovation law, intellectual property, biomedical ethics, privacy and regulatory framework, and health technology assessment. The project will allow for (i) fundamental expansion of the scope of the R&I activities of all partners to build multidisciplinary excellence facilitating the delivery of ATMPs to patients who need them; (ii) establishment of the high level of decision-making autonomy for the CREATIC, which will allow significant organizational and management changes creating spirit and conditions for cutting-edge research and innovation in the Centre, and (iii) strengthen the smart specialization of the Czech Republic (RIS3 CZ 2021-2027) in the domain of Advanced medicine and drugs through the involvement of actors from the academic, public, private and societal sector. Our approach reflects research priorities and societal challenges outlined in the Pharmaceutical Strategy for Europe, which proposes ‘bedside’ manufacture of highly individualised medicines as a future trend in treating rare diseases with ATMPs.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.
Publications
Total number of publications: 5
2024
-
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice
Frontiers in Medicine, year: 2024, volume: 10, edition: January 2024, DOI
-
Fekální bakterioterapie - metoda, transplantace, nebo podání léčivého přípravku?
Year: 2024, type: Conference abstract
-
Léčivé přípravky s CAR-T lymfocyty a jejich reálná dostupnost pro české a slovenské pacienty
Year: 2024, type: Conference abstract
-
Reálná dostupnost ATMPs (Advanced Therapy Medicinal Products) v České a Slovenské republice
Year: 2024, type:
-
Transplantace fekální mikrobioty – klinická praxe, klinický výzkum a pohled regulačních autorit
Year: 2024, type: